Metamizol Spirig HC 500 mg, Tabletten
7680654550040
CH-65455
Tabletten
Associated product:
METAMIZOLE Spirig HC cpr 500 mg 100 pce
1 / 3
google
Article details
- Package size
- 100
- Selling units
- 100
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
33.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 14.50
Specialties list
Yes
Generic
Yes
SL addition date:
01/04/2016
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 65455
- Drug name
- Metamizol Spirig HC, Tabletten
- Galenic form
- TAB
- ATC Code
- N02BB02
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 27/11/2015
- Authorization expiration date
- 31/12/9999
- IT Number
- 01.01.1.
- Domain
- Human medicine
Package details
- Description (FR)
- METAMIZOLE Spirig HC cpr 500 mg 100 pce
- Description (DE)
- METAMIZOL Spirig HC Tabl 500 mg 100 Stk
- Market launch
- 27/11/2015
- Narcotic (BTM)
- No
Original drug
Minalgin, Injektionslösung i.m., i.v.
GTIN: 7680147460641
CHF 13.05